Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (March 30th, 2019)
A weekly review of only the most important cannabis news to impact your portfolio...
CRON
Cronos Q4 2018 Earnings Review – The New Most Expensive Stock in Cannabis
In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with operations. Impressive.
Tilray Q4 2018 Earnings – Eye Watering Stock Price Hard to Justify
Tilray's first quarter with recreational sales failed to impress. Question marks remain how the company will grow into...
HEXO Q2 2019 Earnings – On the Edge of Profitability
A full review of HEXO Q2 2019 earnings. Should you buy this value priced name or are there better cannabis options out there?
Altria Invests $2.4 Billion in Cronos Group
Altria Group, Inc. (NYSE: MO) today acquired 45% of cannabis company Cronos Group Inc. (NASDAQ: CRON; TSX: CRON)...
Canopy Growth Q2 2019 Earnings Review – Big Growth With a Big Cost Structure to Match
Will Canopy Growth's (TSE: WEED; NYSE: CGC) earnings drive the sector to new highs or will results throw...
Aurora Cannabis Q2 2019 Earnings Review – Recreational Ramp Slower Than Expected
Based on Aurora's results, investors may have to wait until 2020 for cannabis stocks to generate any earnings...
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (February 9th, 2019)
Why you should be careful owning cannabis stocks into earnings next week, US states cracking down on CBD,...
Aphria Q2 2019 Earnings Review – Management Cloud Lifted, Assets Free to Shine
With management stepping down and the short seller moving on, Aphria is once again an attractive target for...